JPAVF yields 2.85% · JNJ yields 2.14%● Live data
📍 JPAVF pulled ahead of the other in Year 1
Combined, JPAVF + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of JPAVF + JNJ for your $10,000?
Japan Aviation Electronics Industry, Limited designs, manufactures, and sells connectors, user interface solutions, and aerospace and related electronics in Japan. The company offers input/output, board-to-board, board-to-FPC/FFC, board-to-cable, circular, rectangular, fiber optic, coaxial, cable-to-cable, memory card, memory module, high current connector, charging and discharging plug, and tool connectors; and USB, HDMI, thunderbolt, mini card, M.2 (NGFF), MXM3.0, DDR3 SODIMM, SIM card, microSD card, CompactFlash, coaxial, fiber optic, and active optical cable standard connectors. It also provides user interface solutions, such as capacitive touch panels and overlays, panel switches, teaching pendants, medical device panels, and touch panel monitors. In addition, the company offers motion sensor solutions, such as accelerometers, magnetometers, directional modules, inclinometer packages, coil for linear motor, ring lase and fiber gyro, resolver, and inertial measurement units for the aerospace, automobile mobility, railway, construction agricultural equipment, semiconductor, energy, ocean, civil engineering, and camera stabilization sectors. Its products are used in various applications, such as mobile devices, PC/digital consumer electronics/LED lighting products, infrastructure products, factory automation/robots, automotive/electrical vehicles, railway products, and medical systems. Japan Aviation Electronics Industry, Limited was incorporated in 1950 and is headquartered in Tokyo, Japan.
Full JPAVF Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.